Clinical Trial Update: FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A ClinicalTrials.gov entry describes the 3B-FOLFOX study, a Phase 1/2 trial of FOLFOX and Bevacizumab combined with Botensilimab and Balstilimab for metastatic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Balstilimab (balstilimab)
• Bevacizumab (bevacizumab)
• Botensilimab (botensilimab)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING